These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30779910)

  • 1. Ca
    Sun L; Chen Y; Luo H; Xu M; Meng G; Zhang W
    Biochem Pharmacol; 2019 May; 163():194-205. PubMed ID: 30779910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitor 1 of Protein Phosphatase 1 Regulates Ca
    Luo H; Song S; Chen Y; Xu M; Sun L; Meng G; Zhang W
    Oxid Med Cell Longev; 2019; 2019():2193019. PubMed ID: 31885777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydromyricetin regulates RIPK3-CaMKII to prevent necroptosis in high glucose-stimulated cardiomyocytes.
    Sun L; Xiao Y; San W; Chen Y; Meng G
    Heliyon; 2024 Apr; 10(7):e28921. PubMed ID: 38596141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca
    Hua Y; Qian J; Cao J; Wang X; Zhang W; Zhang J
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca2+/Calmodulin-Dependent Protein Kinase II Regulation by Inhibitor 1 of Protein Phosphatase 1 Protects Against Myocardial Ischemia-Reperfusion Injury.
    Yu J; Chen Y; Xu M; Sun L; Luo H; Bao X; Meng G; Zhang W
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):460-473. PubMed ID: 31030549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory mechanism of CaMKII δ mediated by RIPK3 on myocardial fibrosis and reversal effects of RIPK3 inhibitor GSK'872.
    Zhang J; Cao J; Qian J; Gu X; Zhang W; Chen X
    Biomed Pharmacother; 2023 Oct; 166():115380. PubMed ID: 37639745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PP1γ functionally augments the alternative splicing of CaMKIIδ through interaction with ASF.
    Huang C; Cao W; Liao R; Wang J; Wang Y; Tong L; Chen X; Zhu W; Zhang W
    Am J Physiol Cell Physiol; 2014 Jan; 306(2):C167-77. PubMed ID: 24196533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RIPK3-Mediated Necroptosis in Diabetic Cardiomyopathy Requires CaMKII Activation.
    Chen Y; Li X; Hua Y; Ding Y; Meng G; Zhang W
    Oxid Med Cell Longev; 2021; 2021():6617816. PubMed ID: 34194608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Regulatory Mechanism and Effect of Receptor-Interacting Protein Kinase 3 on Phenylephrine-Induced Cardiomyocyte Hypertrophy.
    Wang X; Zhang J; Qian J; Cao J; Zhang W; Jiang Y
    J Cardiovasc Pharmacol; 2022 Aug; 80(2):236-250. PubMed ID: 35561290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RIPK3 interactions with MLKL and CaMKII mediate oligodendrocytes death in the developing brain.
    Qu Y; Tang J; Wang H; Li S; Zhao F; Zhang L; Richard Lu Q; Mu D
    Cell Death Dis; 2017 Feb; 8(2):e2629. PubMed ID: 28230861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca
    Zhang J; Qian J; Cao J; Wang X; Zhang W; Gu X
    Oxid Med Cell Longev; 2022; 2022():7941374. PubMed ID: 36046685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue of cardiac failing and remodelling by inhibition of protein phosphatase 1γ is associated with suppression of the alternative splicing factor-mediated splicing of Ca2+/calmodulin-dependent protein kinase δ.
    Liao RJ; Tong LJ; Huang C; Cao WW; Wang YZ; Wang J; Chen XF; Zhu WZ; Zhang W
    Clin Exp Pharmacol Physiol; 2014 Dec; 41(12):976-85. PubMed ID: 25224648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arctiin protects rat heart against ischemia/reperfusion injury via a mechanism involving reduction of necroptosis.
    Chen H; Tang LJ; Tu H; Zhou YJ; Li NS; Luo XJ; Peng J
    Eur J Pharmacol; 2020 May; 875():173053. PubMed ID: 32135123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca
    Cao J; Zhang J; Qian J; Wang X; Zhang W; Chen X
    Front Cardiovasc Med; 2022; 9():847362. PubMed ID: 35571197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis.
    Zhang T; Zhang Y; Cui M; Jin L; Wang Y; Lv F; Liu Y; Zheng W; Shang H; Zhang J; Zhang M; Wu H; Guo J; Zhang X; Hu X; Cao CM; Xiao RP
    Nat Med; 2016 Feb; 22(2):175-82. PubMed ID: 26726877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Regulatory Effect of Receptor-Interacting Protein Kinase 3 on CaMKIIδ in TAC-Induced Myocardial Hypertrophy.
    Qian J; Zhang J; Cao J; Wang X; Zhang W; Chen X
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MLKL and CaMKII Are Involved in RIPK3-Mediated Smooth Muscle Cell Necroptosis.
    Zhou T; DeRoo E; Yang H; Stranz A; Wang Q; Ginnan R; Singer HA; Liu B
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglycemia Acutely Increases Cytosolic Reactive Oxygen Species via
    Lu S; Liao Z; Lu X; Katschinski DM; Mercola M; Chen J; Heller Brown J; Molkentin JD; Bossuyt J; Bers DM
    Circ Res; 2020 May; 126(10):e80-e96. PubMed ID: 32134364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on recovery during acidosis in cardiac myocytes overexpressing CaMKII.
    Sag CM; Dybkova N; Neef S; Maier LS
    J Mol Cell Cardiol; 2007 Dec; 43(6):696-709. PubMed ID: 17950750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of CaMKII as a key regulator of reactive oxygen species production in diabetic rat heart.
    Nishio S; Teshima Y; Takahashi N; Thuc LC; Saito S; Fukui A; Kume O; Fukunaga N; Hara M; Nakagawa M; Saikawa T
    J Mol Cell Cardiol; 2012 May; 52(5):1103-11. PubMed ID: 22394624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.